CNSX:ATT - Abattis Bioceuticals Price Target & Analyst Ratings

C$0.08
0.00 (0.00 %)
(As of 08/18/2019 04:00 PM ET)
Add
Today's Range
C$0.08
Now: C$0.08
C$0.08
50-Day Range
C$0.08
MA: C$0.08
C$0.08
52-Week Range
C$0.05
Now: C$0.08
C$0.74
VolumeN/A
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Abattis Bioceuticals (CNSX:ATT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Abattis Bioceuticals in the last 12 months. Their average twelve-month price target is C$0.30, suggesting that the stock has a possible upside of 275.00%. The high price target for ATT is C$0.30 and the low price target for ATT is C$0.30. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$0.30C$0.30C$0.30C$0.30
Price Target Upside: 275.00% upside3.45% upside3.45% upside3.45% upside

Abattis Bioceuticals (CNSX:ATT) Consensus Price Target History

Abattis Bioceuticals (CNSX:ATT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
8/22/2018Fundamental ResearchInitiated CoverageBuy$0.30View Rating Details
(Data available from 8/18/2017 forward)
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: What is a death cross?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel